Published December 2012 | Version v1
Journal article

Conducting radiogenomic research – Do not forget careful consideration of the clinical data

  • 1. Aarhus University Hospital (Denmark)
  • 2. University of Cambridge (United Kingdom)
  • 3. Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen (Netherlands)
  • 4. UZ Leuven (Belgium)
  • 5. Technische Universität Dresden (Germany)
  • 6. University of Wisconsin, Madison (United States)
  • 7. The Institute of Cancer Research – Clinical Trials and Statistics Unit (ICR-CTSU), Sutton (United Kingdom)
  • 8. Dr. Bernard Verbeeten Instituut, Tilburg (Netherlands)
  • 9. Institute of Cancer Research, Sutton (United Kingdom)

Description

The field of radiogenomics has evolved substantially over the last few years. Cooperative research groups have been established and high throughput genotyping has become increasingly feasible and affordable. Nevertheless, a number of clinical and dosimetric issues need to be carefully considered in order to fully exploit these new possibilities.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2012.11.004

Additional details

Identifiers

DOI
10.1016/j.radonc.2012.11.004;
PII
S0167-8140(12)00494-X;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
105
Journal Issue
3
Journal Page Range
p. 337-340
ISSN
0167-8140
CODEN
RAONDT

INIS

Country of Publication
Ireland
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
44102244
Subject category
S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS; S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
COOPERATION; DOSIMETRY; GENES; NUCLEOTIDES; RADIOSENSITIVITY
Descriptors DEC
ORGANIC COMPOUNDS; SENSITIVITY

Optional Information

Copyright
Copyright (c) 2012 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.